Uwe Treiber

Ismaninger Str. 22
Munich, BY 81675, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer.

Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 08, 2016

Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.

Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.

Journal: Molecular imaging and biology

Published: October 21, 2015

Comparison of [¹¹C]choline ([¹¹C]CHO) and S(+)-β-methyl-[¹¹C]choline ([¹¹C]SMC) as imaging probes for prostate cancer in a PC-3 prostate cancer xenograft model.

Comparison of [¹¹C]choline ([¹¹C]CHO) and S(+)-β-methyl-[¹¹C]choline ([¹¹C]SMC) as imaging probes for prostate cancer in a PC-3 prostate cancer xenograft model.

Journal: Molecular imaging and biology

Published: August 29, 2014

11C-Choline PET/pathology image coregistration in primary localized prostate cancer.

11C-Choline PET/pathology image coregistration in primary localized prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 21, 2014

Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer.

Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer.

Journal: Journal of hematology & oncology

Published: December 27, 2013

Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy.

Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy.

Journal: Urologia internationalis

Published: September 16, 2013

Utility of ATP7B in prediction of response to platinum-based chemotherapy in urothelial bladder cancer.

Utility of ATP7B in prediction of response to platinum-based chemotherapy in urothelial bladder cancer.

Journal: Anticancer research

Published: September 12, 2013

Nuclear matrix protein 22 for bladder cancer detection: comparative analysis of the BladderChek® and ELISA.

Nuclear matrix protein 22 for bladder cancer detection: comparative analysis of the BladderChek® and ELISA.

Journal: Anticancer research

Published: November 17, 2012

Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimens.

Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimens.

Journal: European journal of nuclear medicine and molecular imaging

Published: August 17, 2012

[[¹¹C]choline as a pharmacodynamic marker for docetaxel therapy. Response assessment in a LNCaP prostate cancer xenograft mouse model].

[[¹¹C]choline as a pharmacodynamic marker for docetaxel therapy. Response assessment in a LNCaP prostate cancer xenograft mouse model].

Journal: Nuklearmedizin. Nuclear medicine

Published: July 17, 2012

Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.

Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.

Journal: European urology

Published: October 15, 2011

Gender and body mass index as risk factors for bladder perforation during primary transurethral resection of bladder tumors.

Gender and body mass index as risk factors for bladder perforation during primary transurethral resection of bladder tumors.

Journal: The Journal of urology

Published: October 05, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026